- cafead   Oct 02, 2023 at 10:42: AM
via Genetic medicines biotech Lexeo Therapeutics and immune-focused French company Abivax both filed for their initial public offerings on Friday. Neither company specified how much they were seeking to raise in their respective SEC filings.
article source
article source